Spatiotemporal Dimensions of Metabolism in Autochthonous Tumors of GBM Patients

Active, not recruitingOBSERVATIONAL
Enrollment

2

Participants

Timeline

Start Date

September 11, 2023

Primary Completion Date

January 22, 2024

Study Completion Date

December 31, 2025

Conditions
Glioblastoma Multiforme
Interventions
PROCEDURE

Surgical removal of the GBM tumor

Surgical removal of the GBM tumor

OTHER

d4-NAM infusion

Following the surgical removal of the GBM tumor, GBM patients will be dosed with a form of nicotinamide (a natural vitamin) that we can track. The nicotinamide will be converted to methyl nicotinamide (MeNAM) in the tumor. We will measure how fast the nicotinamide is converted to methyl nicotinamide. We believe that the speed of this chemical reaction in the tumor (fast versus slow) may be correlated with GBM aggressiveness.

Trial Locations (1)

32804

AdventHealth Translational Research Institute, Orlando

All Listed Sponsors
lead

AdventHealth Translational Research Institute

OTHER